Skip to content

Testing a Psychotherapy for Anxiety Disorders

Efficacy of Self-Determination Theory-informed Cognitive Behavior Therapy in Anxiety Disorders - None

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101936
Enrollment
33
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F400- Agoraphobia Health Condition 2: F401- Social phobias Health Condition 3: F410- Panic disorder [episodic paroxysmal anxiety] Health Condition 4: F411- Generalized anxiety disorder Health Condition 5: F419- Anxiety disorder, unspecified Health Condition 6: F402- Specific (isolated) phobias

Interventions

Intervention1: Self-Determination Theory-informed Cognitive Behavior Therapy for anxiety disorders: A single group pre-post study where 33 anxiety disorder patients will receive Self-Determination The

Sponsors

National Institute of Mental Health and Neurosciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of an anxiety disorder according to ICD 11 Aged between 18 to 45 years Educated up to a minimum of 10th standard

Exclusion criteria

Exclusion criteria: Comorbid diagnosis of organic disorders or severe mental disorders (e.g., psychotic disorders, substance use disorders) that may hinder engagement in the intervention. History of neurodevelopmental disorders like Autism Spectrum Disorders, ADHD, and IDD. Current engagement in psychotherapy, or having received psychotherapy within the past three months. Acute issues like suicidality

Design outcomes

Primary

MeasureTime frame
anxiety, well-being, basic psychological need satisfaction, perceived meaning in lifeTimepoint: Pre- and post-intervention (T0, T12)

Secondary

MeasureTime frame
Non-specific factors of therapy, i.e., Credibility, Expectancy, and Working allianceTimepoint: Periodically, once in two sessions (T0, T2, T4,...);Treatment AdherenceTimepoint: Every session starting from the second session (T1, T2, T3, ...)

Countries

India

Contacts

Public ContactSarika P S

National Institute of Mental Health and Neurosciences, Bangalore

narendra.samantaray@gmail.com8763331977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026